Actinium Pharmaceuticals, Inc. (ATNM)
Stock-Based Compensation
$118.00K
Quarterly · Period ending: · USD
ATNM Stock-Based Compensation
Latest reported$118.00Kperiod ending
Latest reported$118.00Kperiod ending
ATNM Quarterly Stock-Based Comp ($0.00 → $118.00K)
Quarterly stock-based compensation
High-resolution chart · PNG
ATNM stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 118,000 | |
| 0 | |
| 10,000 | |
| 109,000 | |
| 197,000 | |
| 8,874,000 | |
| 1,203,000 | |
| 1,337,000 | |
| 1,374,000 | |
| 1,378,000 | |
| 927,000 | |
| 921,000 | |
| 1,001,000 | |
| 0 | |
| 979,000 | |
| 970,000 | |
| 425,000 | |
| 421,000 | |
| 448,000 | |
| 411,000 | |
| 0 | |
| 376,000 | |
| 384,000 | |
| 288,000 | |
| 210,000 | |
| 372,000 | |
| 311,094 | |
| 390,544 | |
| 276,680 | |
| 316,389 | |
| 386,952 | |
| 405,939 | |
| 425,825 | |
| 579,939 | |
| 639,631 | |
| 681,821 | |
| 1,141,670 | |
| 1,030,609 | |
| 1,219,964 | |
| 1,015,529 | |
| 1,077,448 | |
| 984,837 | |
| 753,823 | |
| 1,133,578 | |
| 2,266,054 | |
| 2,908,167 | |
| 1,058,956 | |
| 2,080,529 | |
| 1,390,218 | |
| 1,750,926 | |
| 373,441 | |
| 95,971 | |
| 94,200 | |
| 94,200 | |
| 2,223,926 | |
| 72,100 | |
| 40,410 | |
| 199,990 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |